Hanmer & Partners

What Hanmer & Partners does

Zybio Inc. is a privately held Chinese in vitro diagnostics (IVD) manufacturer headquartered in Chongqing, founded in May 2008 with 10 million RMB initial registered capital. The company develops, manufactures, and sells diagnostic reagents and equipment across eight core IVD disciplines: clinical chemistry, immunoassay (CLIA), molecular diagnostics, point-of-care testing (POCT), hematology, microbiology, hemostasis, and urinalysis, plus a dedicated veterinary product line. Its product portfolio spans the EXS 2600/3000 MALDI-TOF mass spectrometry systems, EXI 1800/2400/1820 chemiluminescence analyzers, EXC 200/400 clinical chemistry analyzers, EXM 3000/6000 nucleic acid isolation systems, EXP 160/ZIP-96V real-time PCR systems, YX-2000/3000 coagulation analyzers, Z3/Z50/EXZ 6000/EXZ 8000 hematology analyzers, U3600/U1600/U2610 urinalysis systems, and a comprehensive reagent menu across all categories. Proprietary technology platforms include genetic engineering antigens/antibodies, diagnostic nanomaterials, magnetic separation technology for CLIA, rare earth element fluorescent microsphere labeling for POCT, and MOCAP dual-method optical-mechanical coagulation analysis.

Zybio generates revenue primarily through hardware sales of diagnostic instruments and consumable reagent kits, supplemented by technical services, training, and a 12-month warranty. Manufacturing capacity reaches 3.0 billion reagent kits per year and 35,000 instruments per year across 19 production lines and a 100,000 m² plant. The company runs a sales-led, multi-channel go-to-market. Domestically, 79 service teams across 31 Chinese provinces deliver a 1-hour response and 12-hour on-site service SLA. Internationally, Zybio distributes through wholly-owned subsidiaries in Indonesia, Thailand, Philippines, Brazil, Mexico, Pakistan, Russia, and the Netherlands, supported by 300+ integrated Sales, Application, and Service engineers, complemented by an international distributor network reaching 100+ countries and 13,000+ hospitals. The company maintains ISO 9001 and ISO 13485 certifications, an IFCC-RELA compliant reference measurement laboratory, CNAS accreditation, CE certification on select products, and obtained IFCC C-CB listing for its hs-cTnI assay in August 2025.

Zybio invests more than 15% of sales revenue in R&D, with 30%+ of its 3,300+ workforce in R&D and nearly 50% of R&D personnel holding master's degrees or above. The company operates eight R&D centers across China (Chongqing, Beijing, Guangzhou, Shenzhen, Nanjing, Xiamen, Changchun, Shanghai) and runs an authorized postdoctoral programme. Recent strategic moves include the 2020 acquisition of Xiamen Mass Spectrometry to anchor MALDI-TOF MS, the 2025 launch of an IFCC-auspiced DiagHub Online Academic Platform across five topical sessions, and coordinated EuroMedLab 2025, ADLM 2025, and ESCMID 2025 international showcases. The company's unmatched scale among Chinese IVD manufacturers of comparable origin, paired with deepened EU and US regulatory credentials, positions it as a Chinese IVD export-platform play.

Name

Hanmer & Partners

Legal name

Zybio Inc.

Website

https://hanmermsl.com

Company type

Private

Founded year

2008

Operating status

Operating

Headcount range

251–500 employees

Short description

Zybio Inc. is a Chinese IVD manufacturer that develops and sells diagnostic reagents and equipment across eight disciplines (clinical chemistry, immunoassay, molecular, POCT, hematology, microbiology, hemostasis, urinalysis) plus veterinary, serving 13,000+ hospitals in 100+ countries from its Chongqing headquarters.

Ownership category

akta.pro rank

Product category

In Vitro Diagnostics

NAICS

In-Vitro Diagnostic Substance Manufacturing (325413), Analytical Laboratory Instrument Manufacturing (334516)

SIC

In Vitro & In Vivo Diagnostic Substances (2835), Laboratory Analytical Instruments (3826)

akta.pro primary industry

IVD Reagents, Assay Kits & Consumables (Non-instrument) (HLAHAAAM)

akta.pro secondary industries

Biomarker Assay & Reagent Development (LDT/IVD assay design, antibodies/standards/controls) (HLAAAMAL), Clinical Chemistry & Hematology Diagnostics (automated analyzers, blood testing) (HLAAALAH), Reference Laboratory Testing (Clinical Pathology & Chemistry) (HLAMADAA), Reagents, Chemicals & Assay Kits (Buffers, Antibodies, ELISA, Enzymes) (HLAGAIAI), Hematology & Coagulation Diagnostics (HLAHAAAB)

Keywords

• In vitro diagnostics
• Clinical laboratory equipment
• Molecular diagnostic reagents
• Immunoassay analyzers
• Veterinary diagnostics

Headquarters

HQ city

Mumbai

HQ country

India

HQ region

Asia

Offices17 records

Markets served

GTM type

B2B

Offering type

Hardware or Manufacturing

Cost components

Personnel, Technology or R&D, Operations, Marketing or Sales, Supply Chain, Infrastructure

Revenue model

1. In Vitro Diagnostic Reagents: Manufacture and sale of IVD reagents across multiple categories including clinical chemistry, immunoassay, molecular, POCT, hematology, microbiology. Production capacity of 3.0 billion kits of reagent per year.
2. Diagnostic Equipment/Instruments: Manufacture and sale of diagnostic equipment including analyzers and systems. Current production capacity of 35,000 equipment per year.
3. Technical Services and Support: After-sales service, training, and technical support provided to customers globally. 12-month warranty offered for all warranted products.

Go-to-market motion3 records

Distribution channels4 records

Marketing channels5 records

Core offering

Hanmer & Partners manufactures and sells in vitro diagnostic (IVD) reagents and instruments across eight disciplines — microbiology, molecular diagnostics, chemiluminescence immunoassay, clinical chemistry, point-of-care testing, hemostasis, hematology, and urinalysis — alongside a dedicated veterinary diagnostics product line. The portfolio spans automated analyzers (e.g., MALDI-TOF mass spectrometers, PCR systems, immunoassay analyzers, chemistry analyzers, hematology and coagulation analyzers, urinalysis systems), reagent kits and consumables, and post-sale service, training, and technical support delivered through direct service teams and overseas subsidiaries.

Product overview

Zybio is a high-tech enterprise specializing in IVD reagents and equipment R&D, manufacture, sales and technical services. The company offers a comprehensive portfolio of in vitro diagnostic products spanning eight core categories: Microbiology (MALDI-TOF mass spectrometry systems EXS 2600/3000, blood culture system EXB 120, and reagents), Molecular Diagnostics (nucleic acid isolation systems EXM 3000/6000, real-time PCR systems EXP 160/960, ZIP-96V, and extraction/detection reagent kits), CLIA (automated immunoassay analyzers EXI 1800/2400/1820 with comprehensive reagent menu), Clinical Chemistry (automated analyzers EXC 200/400 with 100+ reagent items), POCT (fluorescence and colloidal gold immunoassay systems Q8 Pro, EXR110/120, and rapid antigen/antibody test kits), Hemostasis (automated coagulation analyzers YX-2000/3000 with MOCAP dual-method technology), Hematology (3/5/6-diff analyzers Z3, Z3 CRP, Z50, EXZ 6000/8000 with corresponding reagents), and Urinalysis (hybrid systems U3600, chemistry analyzer U1600, sediment analyzer U2610). Additionally, Zybio offers dedicated veterinary diagnostics (VET series including EXM, EXP, Z4 VET, Z52 VET products) and the DiagHub Online Academic Platform for continuous education. The product ecosystem integrates through shared reagent platforms and LIS connectivity, enabling laboratories to build comprehensive diagnostic solutions from point-of-care testing to central laboratory automation.

Differentiator

Problem solved

Functional benefit

Brands

• DiagHub: Online academic platform for knowledge sharing and professional education in diagnostics
• MOCAP
• 雁行 (Yànxíng)

Products and services

• EXS 2600 MALDI-TOF Mass Spectrometry System MALDI-TOF mass spectrometry system for rapid microorganism identification in microbiology laboratories; 7-minute identification time per plate with 96 sample spots.
• EXS 3000 MALDI-TOF Mass Spectrometry System MALDI-TOF mass spectrometry system with solid laser (1-200 Hz frequency) for microbial identification; 125kg instrument for clinical microbiology workflows.
• EXB 120 Blood Culture System Chromogenic-method blood culture system with dual-chamber (A/B) design and 120 independent sample positions; continuous monitoring with fastest reporting time of 3 hours.
• Microbiology Pretreatment Reagents Pretreatment reagent kits for MALDI-TOF workflows including Sample Treatment Matrix Solution, Mold Sample Pretreatment Kit, Blood Culture Positive Sample Pretreatment Kit, and Microbe Sample Pretreatment Kit.
• EXM 6000 Nucleic Acid Isolation System High-throughput molecular diagnostics instrument for DNA/RNA extraction from clinical samples via magnetic bead method; processes 1-96 samples in 12 minutes with ≥98% recovery.
• EXM 3000 Nucleic Acid Isolation System Automated nucleic acid isolation system using magnetic bead method; processes 1-32 samples in 9 minutes with ≥98% recovery rate and ≤3% CV.
• Magnetic Bead Nucleic Acid Extraction Kit Magnetic bead-based DNA/RNA extraction kit for serum, plasma, nasopharyngeal swabs, and other samples; ≥90% recovery with 9-minute extraction for 32 viral samples.
• Real-time PCR Detection Kits Real-time PCR detection kits including SARS-CoV-2, SARS-CoV-2 & Influenza A/B, Molaccu COVID-19, and RUO amplification detection kits for various pathogens.
• Disposable Virus Sampling Tube (VTM) Virus sampling tube with efficient inactivation technology and flocked swabs for collection and storage of clinical specimens including SARS-CoV-2, influenza, avian influenza (e.g., H7N9), hand-foot-mouth, measles, chlamydia, mycoplasma, and ureaplasma.
• ZIP-96V Quantitative Real-Time PCR System 96-well quantitative real-time PCR system based on Fresnel lens optical signal acquisition; 4 fluorescent channels, 96 tests per run, CE certified.
• EXP 160 Fast Real-Time PCR System Fast real-time PCR system with two independent 8-well thermal modules, 4 fluorescent channels, average heating ≥5.8°C/s and cooling ≥4.5°C/s; 16 tests per run in ≤35 minutes.
• EXI 1800 Chemiluminescence Immunoassay Analyzer Fully automated chemiluminescence immunoassay analyzer with 180 T/H throughput and first result in 15 minutes; features magnetic separation patent, non-contact vortex mixing, and multi-module integration.
• EXI 2400 Chemiluminescence Immunoassay Analyzer Fully automated chemiluminescence immunoassay analyzer with 400 T/H throughput and first result in 12.8 minutes; 28 reagent positions, 100+5 sample positions, homogeneous biotin-streptavidin reaction technology.
• EXI 1820 Chemiluminescence Immunoassay Analyzer Fully automated chemiluminescence analyzer with optimized magnetic separation and online vortex mixing; 200 T/H throughput with dedicated STAT port for emergency samples in 30 seconds.
• Chemiluminescence Reagent Menu Comprehensive CLIA reagent menu covering thyroid, fertility, tumor markers, cardiac, inflammation, diabetes, bone metabolism, gastric, anemia, and SARS-CoV-2 markers.
• EXC 400 Automated Clinical Chemistry Analyzer Automated floor-standing chemistry analyzer with 400 T/H throughput, 100+ original reagents, 24-hour non-stop refrigeration, bilateral LIS interface, and minimum reaction volume of 180 μL.
• EXC 200 Automated Desktop Clinical Chemistry Analyzer Automated desktop chemistry analyzer for small healthcare institutions with throughput up to 240 T/H; 40 sample positions, 40 reagent positions, 24-hour non-stop refrigeration.
• Clinical Chemistry Reagent Menu Over 100 clinical chemistry reagent items covering hepatic, renal, lipids, cardiac, diabetes, coagulation, specific proteins, electrolytes, inflammation, and pancreatitis panels.
• SARS-CoV-2 Antigen and Antibody Rapid Test Kits Colloidal gold-based lateral flow immunoassays for qualitative SARS-CoV-2 antigen detection (15 minutes), SARS-CoV-2 & Influenza A/B multiplex (15-20 minutes), and SARS-CoV-2 IgM/IgG antibody detection (15 minutes). Available in professional and self-testing versions.
• Q8 Pro POCT Immunoassay System Fluorescence-based POCT immunoassay system using rare-earth-element fluorescent microsphere labeling; 25 channels, 15-inch HD touch screen, results in 3-15 minutes.
• EXR110/EXR120 Fluorescence Immunochromatography Analyzer Fluorescence immunochromatography analyzer with 3 channels, 8-inch screen, rare-earth-element fluorescent microsphere labeling, 3-15 minute results, and optional built-in battery.
• YX-2000 Automated Blood Coagulation Analyzer Automated blood coagulation analyzer with MOCAP technology integrating mechanical and optical coagulation detection; 320 T/H throughput, 20 reagent positions, 40 sample capacity, LED light source.
• YX-3000 Automated Blood Coagulation Analyzer Automated blood coagulation analyzer with MOCAP technology and 410 T/H throughput; 39 reagent positions (35 refrigerated), dual magnetic bead and transmission optical detection methods.
• Z3 3-Diff Hematology Analyzer 3-diff hematology analyzer with impedance counting and colorimetric HGB; 70 samples/h, 21 parameters, 3 histograms, 10.4-inch touch screen, weighs under 20 kg.
• Z3 CRP Hematology Analyzer with CRP 3-diff hematology analyzer with integrated CRP module for combined CBC and CRP testing using 15 μL whole blood; results in 1 minute with 'zero' carryover CRP cuvette.
• Z50 5-Diff Hematology Analyzer 5-diff hematology analyzer using tri-angle laser scatter and flow cytometry for WBC differentiation; 60 samples/h, 29 parameters, 5 scattergrams.
• EXZ 6000 Automated Hematology Analyzer Automated hematology analyzer with flow cytometry and tri-angle laser scatter for 5-diff differentiation; ≥90 samples/h CBC, ≥70 samples/h CBC+DIFF, supports capillary blood with ≤20 μL sample.
• EXZ 8000 6-Diff Hematology Analyzer 6-diff hematology analyzer with next-generation nucleic acid fluorescent dye technology; 120 samples/h with flexible combo testing of CBC + DIFF + NRBC + RET.
• Hematology Reagents Professional hematology reagents designed for use with Zybio's hematology analyzers.
• U3600 Automated Urinalysis Hybrid System Automated urinalysis hybrid system with laminar flow technology and high-speed photography; medical image recognition for automatic classification of 25+ formed particles, carryover under 0.05%.
• U1600 Urine Chemistry Analyzer and U2610 Urine Sediment Analyzer U1600 chemistry analyzer with 240 T/H throughput, 8-inch touch screen, Color/Specific Gravity/Turbidity parameters; U2610 sediment analyzer with 150 T/H throughput, 6×10 sample positions with STAT priority, and conductivity/osmolality measurement.
• Veterinary EXM 3000 Nucleic Acid Isolation System Veterinary nucleic acid isolation system using magnetic bead method; 1-32 samples, ≤20-minute extraction, 95%+ nucleic acid recovery, 98%+ magnetic bead recovery, UV light and HEPA filter.
• Veterinary EXM 6000 Nucleic Acid Isolation System High-throughput veterinary nucleic acid isolation system; 1-96 samples with ≥98% recovery rate, multi-level anti-pollution design with negative pressure ventilation.
• Veterinary EXP 160 Fast Real-Time PCR System Fast real-time PCR system for veterinary diagnostics with two independent 8-well thermal modules; 4 fluorescent channels, average heating ≥5.8°C/s, 12.5 kg weight.
• Veterinary EXP 960 Real-Time PCR System Quantitative real-time PCR system for 96 samples with 6 fluorescent channels; average heating ≥6.5°C/s, cooling ≥3.5°C/s, dynamic range 100-10^10 copies.
• Veterinary Nucleic Acid Extraction Kit PRT DNA & RNA Extraction Kit using magnetic bead method for various animal samples including blood, plasma, swabs, and tissue; manual extraction 16 samples in 30 min, EXM3000: 32 samples in 17 min.
• Veterinary Nucleic Acid qPCR Detection Kit Real-time PCR detection kits for animal pathogens including African Swine Fever Virus (200 copies/mL LOD) and Foot-and-Mouth Disease Virus (all 7 serotypes).
• Z4 VET 4-Diff Veterinary Hematology Analyzer 4-diff veterinary hematology analyzer with independent two-chamber counting system for accurate eosinophil detection; 23 parameters and 4 histograms in 1 minute, under 0.12 m² footprint.
• Z52 VET 5-Diff Veterinary Hematology Analyzer 5-diff veterinary hematology analyzer using laser-scattering and flow cytometry; 25 parameters, 5 scattergrams, 3 histograms in 1 minute, under 0.16 m² footprint.
• Service, Warranty, and Technical Support Program Global service network with 1-hour response, 12-hour on-site support commitment, 12-month product warranty, free training programs, and online training delivered through the DiagHub platform.
• DiagHub Online Academic Platform Online academic platform under IFCC auspices hosting expert sessions on clinical chemistry, immunology, microbiology, urinalysis, and POCT for continuous professional education in clinical diagnostics.

Quantifiable outcome

• MALDI-TOF MS dispersion method achieves 83.67% species-level identification accuracy vs 76.53% for traditional method, with ~40% time saved
• +5 more outcomes

Named customers2 records

Segments4 records

Ideal customer profiles3 records

Technology focussed Yes

API detail

Has API

No

API docs

API detail

Core technology

AI maturity

App detail

Feature9 records

Scale indicators15 records

Recent moves9 records

Expansion highlights6 records

Broad incumbents

• Beckman Coulter (Danaher): Global IVD incumbent in clinical chemistry, immunoassay, hematology, and urinalysis. Direct overlap with Zybio's chemistry, immunoassay, hematology, and urinalysis systems.
• Roche Diagnostics: Global IVD leader and primary competitor across all eight Zybio disciplines. Sets the performance and quality benchmark that Zybio's IFCC C-CB and ESCMID recognitions benchmark against.
• Siemens Healthineers: Global IVD and imaging incumbent; directly competes on clinical chemistry (Atellica), immunoassay, and hematology systems that overlap Zybio's EXC, EXI, and EXZ product lines.
• Bruker: Established MALDI-TOF MS (Biotyper) microbiology identification incumbent. Most relevant global competitor to Zybio's EXS 2600/3000 MALDI-TOF platform following the Xiamen Mass Spectrometry acquisition.
• Abbott Diagnostics: Multinational IVD incumbent with broad chemistry, immunoassay, hematology, and molecular diagnostics portfolio. Competes with Zybio on global hospital tenders, particularly in emerging markets.

Direct peers

• Maccura Biotechnology: Chinese IVD company with strong clinical chemistry, immunoassay, and hematology reagent businesses. Competes with Zybio on chemistry and hematology analyzer platforms.
• Autobio Diagnostics: Chinese IVD manufacturer focused on immunoassay, microbiology, and clinical chemistry analyzers/reagents. Direct Chinese peer across multiple of Zybio's eight diagnostic disciplines.
• Mindray: Leading Chinese IVD and patient monitoring manufacturer with comparable multi-discipline reagent/instrument portfolio and global hospital sales channels. Closest large-cap Chinese comparable to Zybio's diversified IVD model.
• Da An Gene (Sun Yat-sen University Da An Gene): Chinese molecular diagnostics and IVD manufacturer. Direct peer to Zybio's molecular diagnostic product line (EXM, EXP, PCR detection kits).
• Snibe (Shenzhen New Industries Biomedical Engineering): Chinese chemiluminescence immunoassay (CLIA) specialist with global installed base. Directly comparable to Zybio's EXI CLIA product line and competes head-to-head on immunoassay menus.

Market position

Strengths5 records

Weaknesses4 records

Competitive moat6 records

Key risks6 records

Key highlights6 records

Customer concentration

• YouTubeyoutube.com/channel/UC5U2ijJJsuziTfjWifiPyNQ
• Facebookfacebook.com/zybio.ji.7?fref=pb&hc_location=friends_tab

Compliance6 records

Revenue estimate

Valuation estimate

Number of profiles

Profiles1 record

Subsidiaries8 records

Funding overview

Funding rounds

Investors

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about Hanmer & Partners